RBC
PFE icon

Romano Brothers & Co’s Pfizer PFE Stock Holding History

Romano Brothers & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Sell
69,523
-1,040
-1% -$27.2K 0.17% 136
2026
Q1 		$1.98M Sell
70,563
-992
-1% -$26.4K 0.23% 113
2025
Q4 		$1.78M Sell
71,555
-4,034
-5% -$102K 0.2% 116
2025
Q3 		$1.93M Buy
75,589
+43
+0.1% +$1.06K 0.22% 114
2025
Q2 		$1.83M Sell
75,546
-3,917
-5% -$91.3K 0.23% 114
2025
Q1 		$2.01M Sell
79,463
-1,555
-2% -$40.7K 0.26% 102
2024
Q4 		$2.15M Sell
81,018
-9,345
-10% -$253K 0.27% 100
2024
Q3 		$2.62M Sell
90,363
-250
-0.3% -$7.29K 0.33% 94
2024
Q2 		$2.54M Sell
90,613
-4,785
-5% -$132K 0.35% 87
2024
Q1 		$2.65M Sell
95,398
-1,530
-2% -$42.5K 0.36% 87
2023
Q4 		$2.79M Sell
96,928
-10,239
-10% -$310K 0.42% 83
2023
Q3 		$3.55M Sell
107,167
-1,191
-1% -$42.1K 0.55% 56
2023
Q2 		$3.97M Sell
108,358
-1,561
-1% -$60.8K 0.59% 52
2023
Q1 		$4.48M Buy
109,919
+226
+0.2% +$9.76K 0.69% 39
2022
Q4 		$5.62M Sell
109,693
-2,790
-2% -$134K 0.85% 28
2022
Q3 		$4.92M Buy
+112,483
New +$5.47M 0.79% 37

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Romano Brothers & Co's PFE Position: Q2 2026 in Review

Romano Brothers & Co reduced its Pfizer (PFE) stake by 1.5% in Q2 2026, selling an estimated $27.2K and leaving 69,523 shares worth $1.67M. The position accounts for 0.17% of the portfolio, ranked #136.

Romano Brothers & Co first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.62M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Romano Brothers & Co held 69,523 shares of Pfizer worth $1.67M as of Q2 2026.
  • Romano Brothers & Co sold 1,040 Pfizer shares in Q2 2026, an estimated $27.2K.
  • Pfizer made up 0.17% of Romano Brothers & Co's portfolio in Q2 2026, its #136 holding.
  • Romano Brothers & Co first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Pfizer position peaked at $5.62M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.